Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
|Podcasts|June 9, 2023
Optimizing Patient Care and Combating Resistance: The Role of Multidisciplinary Collaboration in UTI Management
Author(s)Nina Cosdon
Collaboration and teamwork are essential components in addressing UTI management and antibiotic resistance, explains infectious disease clinical specialist Kim Leuthner, PharmD, FIDSA.
Advertisement
In this final episode of the complicated urinary tract infection (UTI) podcast series, Kim Leuthner, PharmD, FIDSA, discusses the importance of improving personalized medicine for treating complicated UTIs and the role of
Leuthner suggests that electronic health records can be utilized to develop systems for effective communication between hospitals, particularly in sharing information about patients' past medical history of resistance and colonization with multidrug-resistant organisms. This can aid in promptly isolating infected patients and making appropriate empirical treatment choices.
Finally, Leuthner notes the importance of multidisciplinary collaboration among healthcare professionals to achieve successful stewardship and prevent resistance.
This is part 3 of a mini podcast series with Kim Leuthner, PharmD, FIDSA, an infectious disease clinical specialist at the University Medical Center of Southern Nevada.
Advertisement
Related to this article
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Adding bismuth to amoxicillin-vonoprazan increased efficacy of the combination for H pylori, and exceeded that of clarithromycin-based triple therapy without contributing to clarithromycin resistance.
Editor in chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the proposed OMB rule restricting federal grants for international research collaboration, and how it threatens infectious disease medicine's inherently borderless surveillance networks, publication access, and knowledge-sharing systems.
Advertisement
Advertisement
Trending on Contagion Live
1
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
2
How The Food Safety Surveillance Infrastructure Works in the US
3
Evaluating Ebola Vaccine Against Current Bundibugyo Species
4
Implanted Antibiotic Reduced Systemic Regimen for Orthopedic Infection
5